Key facts
- This page summarizes Thibaut Mongon's Form 4 filing for JOHNSON & JOHNSON (JNJ).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 15 Feb 2023, 18:25.
Thibaut Mongon - 13 Feb 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)
- Reporting relationship
- Exec VP, WW Chair, Cons Health
- Issuer ticker
- JNJ
- Reported as of
- 13 Feb 2023
- Net transaction value
- -$1,041,724
- SEC form
- 4
- Accepted by SEC
- 15 Feb 2023, 18:25:06 UTC
- Prior SEC filing
- 14 Feb 2023
- Next SEC filing
- 03 May 2023
- Source filing
- View source filing
- Reporting owner signature
- Raavi K. Deol, as attorney-in-fact for Thibaut Mongon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thibaut Mongon filed Form 4 for JOHNSON & JOHNSON (JNJ) on 15 Feb 2023.
Change
- Previous filing in this sequence was filed on 14 Feb 2023.
- Current net transaction value: -$1,041,724.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JNJ
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +13,710
- Change %
- +23%
- Price
- $0.000000
- Shares after
- 72,345
- Date
- 13 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
JNJ
transaction
Common Stock
Tax liability
- Transaction value
- $1,041,724
- Shares
- -6,430
- Change %
- -8.9%
- Price
- $162.01
- Shares after
- 65,915
- Date
- 13 Feb 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JNJ
transaction
Derivative
Employee Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +56,555
- Change %
- Price
- $0.000000
- Shares after
- 56,555
- Date
- 13 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 56,555
- Exercise price
- $162.75
- Footnotes
- F2
JNJ
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- $0
- Shares
- +3,417
- Change %
- Price
- $0.000000
- Shares after
- 3,417
- Date
- 13 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,417
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020.
Footnote F2
Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
Footnote F3
Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.
Footnote F4
The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.